Supplement

Pharmacoeconomics of Emerging Therapies for Rheumatoid Arthritis

Published Online: June 01, 1999
Arthur Kavanaugh, MD
Log in to access PDF
Issue: Clinical and Economic Opportunities of Anti-TNF Therapies in Rheumatoid Arthritis
SUPPLEMENT CONTENT
Participating Faculty
Introduction
Joan M. Bathon, MD
Pharmacoeconomics of Emerging Therapies for Rheumatoid Arthritis
Arthur Kavanaugh, MD
Methotrexate Therapy in the Year 2000: Outstanding Questions
Michael E. Weinblatt, MD
State-of-the-Art Combination Therapy in 1999
James R. O'Dell, MD
Assessing New Therapies for RA: Defining New Expectations for Treatment; New Therapies in Clinical Practice: Issues of Cost and Access
The Emerging Role of Anti-TNF Therapy in the Treatment of Rheumatoid Arthritis
Peter E. Lipsky, MD
Selected Abstracts
CME Quiz
Bibliography
Click for Full Issue
More on AJMC.COM
No Result Found
About Us | Contact Us | Advertise | Terms & Conditions | Press Room | Copyright HCPLive 2006-2013 | Intellisphere, LLC. All Rights Reserved.
Partner Websites: Pharmacy Times | Targeted Therapies | PainLive | HCPLive | ONCLive